NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S)-2-amino-4-[imino(methyl)oxo-λ6-sulfanyl]butanoic acid
|
(2S)-2-amino-4-[imino(methyl)oxo-$l^{6}-sulfanyl]butanoic acid
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
L-Methionine sulfoximine
|
L-S-[3-Amino-3-carboxypropyl]-S-methyl-[R,S]-sulfoximine
|
(2S)-2-Amino-4-(S-methylsulfonimidoyl)butanoic Acid
|
L-Methionine [R,S]-Sulfoximine
|
(R)-L-S-(3-Amino-3-carboxypropyl)-S-methylsulfoximine
|
[R-(R*,S*)]-2-Amino-4-(S-methylsulfonimidoyl)butanoic Acid
|
(2S,SR)-Methionine Sulfoximine
|
L-Methionine [R]-Sulfoximine
|
L-S-(3-Amino-3-carboxypropyl)-S-methylsulfoximine
|
L-METHIONINE SULFOXIMINE
|
L-S-(3-氨基-3-羧丙基)-S-甲基砜亚胺
|
L-蛋氨酸砜亚胺
|
|
|
CAS Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
1.8865596
|
H Acceptors
|
5
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-4.447861
|
LogD (pH = 7.4)
|
-4.453787
|
Log P
|
-4.446533
|
Molar Refractivity
|
40.2168 cm3
|
Polarizability
|
16.919283 Å3
|
Polar Surface Area
|
104.24 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
MP Biomedicals
Sigma Aldrich
TRC
Sigma Aldrich -
M5379
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Application As a potent inhibitor of glutamine sythetase activity, this reagent has widely been used as a selection agent for plasmid integration in Chinese hamster ovary (CHO) and other mammalian cell lines. The growing demand for high yield cell banks for production of recombinant proteins for therapeutics has resulted in two major systems for selection of stable and active clones, Methotrexate selection of dihydrofolate reductase (DHFR) overexpressing cells and MSX selection of glutamine synthetase overexpressing cells. Cells are grown in the absence of glutamine in the media and inhibition of the endogenous activity of glutamine synthease results in cell death for cells lacking overexpression. The MSX-glutamine synthase selection mechanism provides benefits over that of the Methotrexate-DHFR system in that it typically requires a single amplification step and results in significant reduction of time to produce high stability, highly amplified clones. Biochem/physiol Actions Methionine sulfoximine (MSX) increases ornithine decarboxylase activity, decreases the survival rate in a model of transient cerebral ischemia, and inhibits glutamine synthetase activity. |
Sigma Aldrich -
91016
|
General description Certified content by quantitative NMR incl. uncertainty and expiry are given in the certificate.Download your certificate at: http://www.sigma-aldrich.com. Legal Information TraceCERT is a registered trademark of Sigma-Aldrich Co. LLC |
Toronto Research Chemicals -
M260500
|
Methionine sulfoximine inhibits both glutamine synthetase and g-glutamylcysteine synthetase. Working concentrations for inhibition of g-glutamylcysteine synthetase are 0.2-2.0 mM (52% inhibition occured at 100 mM).Methionine sulfoximine is also a toxic by |
Toronto Research Chemicals -
M260505
|
The R-diastereoisomer of L-Methionine [R,S]-Sulfoximine (M260500). |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Griffith, O.W., and Meister, A.: J. Biol. Chem. 254, 7558 (1979)
- • Willard-Mack, C.L., et al: Neuroscience, 71, 2, 589 (1996)
- • Wilson, J., et al.: J. Exp. Biol., 203, 2297 (2000)
- • Ip, Y., et al.: J. Exp. Biol., 208, 1993 (2000)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent